4,488 followers
First, we now have 2 approved bispecific antibodies+2 CAR-T therapies, all targeting BCMA. This is different than the time Blenrep was initially approved. Those BCMA based therapies are associated with higher ORR/PFS (though no direct comparison) ➡️https: